Abstract:Background: Type 2 diabetes (T2D) is a complex metabolic ailment marked by a global high prevalence and significant attention in primary healthcare settings due to its elevated morbidity and mortality rates. The pathophysiological mechanisms underlying the onset and progression of this disease remain subjects of ongoing investigation. Recent evidence underscores the pivotal role of the intricate intercellular communication network, wherein cell-derived vesicles, commonly referred to as extracellular vesicles (EVs), emerge as dynamic regulators of diabetes-related complications. Given that the protein cargo carried by EVs is contingent upon the metabolic conditions of the originating cells, particular proteins may serve as informative indicators for the risk of activating or inhibiting signaling pathways crucial to the progression of T2D complications. Methods: In this study, we conducted a systematic review to analyze the published evidence on the proteome of EVs from the plasma or serum of patients with T2D, both with and without complications (PROSPERO: CRD42023431464). Results: Nine eligible articles were systematically identified from the databases, and the proteins featured in these articles underwent Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. We identified changes in the level of 426 proteins, with CST6, CD55, HBA1, S100A8, and S100A9 reported to have high levels, while FGL1 exhibited low levels. Conclusion: These proteins are implicated in pathophysiological mechanisms such as inflammation, complement, and platelet activation, suggesting their potential as risk markers for T2D development and progression. Further studies are required to explore this topic in greater detail.

Research progress of extracellular vesicles in type 2 diabetes and its complications

Clinical Potential of Extracellular Vesicles in Type 2 Diabetes

Extracellular vesicles in type 2 diabetes mellitus: key roles in pathogenesis, complications, and therapy

Extracellular vesicles as signaling mediators in type 2 diabetes mellitus

Exosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications

The role of miRNAs carried by extracellular vesicles in type 2 diabetes and its complications

Integrative biology of extracellular vesicles in diabetes mellitus and diabetic complications

Endothelial extracellular vesicles: their possible function and clinical significance in diabetic vascular complications

Exosome-Like Vesicles as New Mediators and Therapeutic Targets for Treating Insulin Resistance and β-Cell Mass Failure in Type 2 Diabetes Mellitus

The interplay of extracellular vesicles in the pathogenesis of metabolic impairment and type 2 diabetes

Exosomes as Emerging Regulators of Immune Responses in Type 2 Diabetes Mellitus

[Exosomes and Their Roles in Diabetes Mellitus and Its Complications: from Pathogenic, Diagnostic and Therapeutical Perspectives].

Research progress on extracellular vesicles in the renal tubular injury of diabetic kidney disease

Extracellular vesicle-shuttled miRNAs: a critical appraisal of their potential as nano-diagnostics and nano-therapeutics in type 2 diabetes mellitus and its cardiovascular complications

Systematic review and bioinformatics analysis of plasma and serum extracellular vesicles proteome in type 2 diabetes

Β-Cell Dynamics in Type 2 Diabetes and in Dietary and Exercise Interventions

Emerging role of extracellular vesicles in diabetic retinopathy

Role of extracellular vesicles in insulin resistance: Signaling pathways, bioactive substances, miRNAs, and therapeutic potential

An overview of the efficacy and signaling pathways activated by stem cell-derived extracellular vesicles in diabetic kidney disease

Extracellular vesicles derived from different sources play various roles in diabetic retinopathy

The roles of mesenchymal stem cell-derived exosomes in diabetes mellitus and its related complications